Proteolysis-targeting chimera against NR4A1 for cancer immunotherapy

被引：0
|
作者：
Wang, Lei
Xiao, Yufeng
Master, Rohan P.
Jin, Zeng
Patel, Urvi M.
Luo, Yuewan
Zhou, Daohong
Zheng, Guangrong
Zhang, Weizhou
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2326
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2326
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
    Jemilat Salami
    Shanique Alabi
    Ryan R. Willard
    Nick J. Vitale
    Jing Wang
    Hanqing Dong
    Meizhong Jin
    Donald P. McDonnell
    Andrew P. Crew
    Taavi K. Neklesa
    Craig M. Crews
    Communications Biology, 1
  • [32] Self-Assembled Peptide-Derived Proteolysis-Targeting Chimera (PROTAC) Nanoparticles for Tumor-Targeted and Durable PD-L1 Degradation in Cancer Immunotherapy
    Moon, Yujeong
    Cho, Hanhee
    Kim, Jinseong
    Song, Sukyung
    Park, Jung Yeon
    Min, Jin Young
    Han, Eun Hee
    Kim, Yongju
    Seong, Joon-Kyung
    Shim, Man Kyu
    Kim, Kwangmeyung
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2025, 64 (05)
  • [33] Discovery of Selective Proteolysis-Targeting Chimera Degraders Targeting PTP1B as Long-Term Hypoglycemic Agents
    Yang, Zunhua
    Ying, Yuqi
    Cheng, Shaobing
    Wu, Jiamin
    Zhang, Ziwei
    Hu, Pei
    Xiong, Jian
    Li, Huilan
    Zeng, Qing
    Cai, Zhifang
    Feng, Yulin
    Fang, Yuanying
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (09) : 7569 - 7584
  • [34] Proteolysis-targeting chimera (PROTAC) delivery system: advancing protein degraders towards clinical translation
    Chen, Yu
    Tandon, Ira
    Heelan, William
    Wang, Yixin
    Tang, Weiping
    Hu, Quanyin
    CHEMICAL SOCIETY REVIEWS, 2022, 51 (13) : 5330 - 5350
  • [35] Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future
    Li, Rui
    Liu, Miao
    Yang, Zhenya
    Li, Jiao
    Gao, Yuxin
    Tan, Ruirong
    MOLECULES, 2022, 27 (24):
  • [36] Therapeutic potential of NR4A1 in cancer: Focus on metabolism
    Deng, Shan
    Chen, Bo
    Huo, Jiege
    Liu, Xin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [37] Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity
    He, Yonghan
    Zhang, Xuan
    Chang, Jianhui
    Kim, Ha-Neui
    Zhang, Peiyi
    Wang, Yingying
    Khan, Sajid
    Liu, Xingui
    Zhang, Xin
    Lv, Dongwen
    Song, Lin
    Li, Wen
    Thummuri, Dinesh
    Yuan, Yaxia
    Wiegand, Janet S.
    Ortiz, Yuma T.
    Budamagunta, Vivekananda
    Elisseeff, Jennifer H.
    Campisi, Judith
    Almeida, Maria
    Zheng, Guangrong
    Zhou, Daohong
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [38] A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth
    Xin Li
    Yuan Yao
    Fangrui Wu
    Yongcheng Song
    Journal of Hematology & Oncology, 15
  • [39] A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth
    Li, Xin
    Yao, Yuan
    Wu, Fangrui
    Song, Yongcheng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [40] Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers
    Cao, Chaoguo
    Yang, Jie
    Chen, Yong
    Zhou, Peiting
    Wang, Yingwei
    Du, Wu
    Zhao, Lifeng
    Chen, Yuanwei
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (19) : 11012 - 11033
12345